| Introduction | For Patients | For Science | For Society | Looking Ahead In 2026, CSL’s Centenary Fellowships reached the conclusion of their planned 10-year program, leaving a lasting legacy for Australian medical research. Established in CSL’s centenary year, the A$25 million AUD initiative supported 20 exceptional early- to mid-career researchers with five years of funding to pursue ambitious discovery and translational research in Australia. Over the decade, the fellowships helped researchers build independent careers, support PhD students and scientific staff, and advance research with the potential to shape future treatments. With the final fellowships now awarded, the program stands as a long-term investment in the people and ideas helping to strengthen Australia’s medical research community and drive the science of tomorrow. science Investing in Medical Dr Con Panousis BSc (Hons), PhD (Biochemistry) | Melbourne, Australia Vice President, Drug Discovery (Biomedical researcher), CSL Research “I’ve spent my career working in drug discovery because I believe in the power of science to improve lives. Today, I work in teams focused on discovering new biologic therapies for people with serious and rare diseases. While my role has evolved over time, what motivates me has remained consistent for the past 30 years – the opportunity to understand disease more deeply and translate that understanding into treatments that can genuinely help patients.” Mollie Barrett BA (Psychology) | California, USA Senior Director, Therapeutic Area Operations – Hematology, CSL Behring “The haematology area is complex and ever evolving, and it often feels like working through a puzzle. This certainly keeps the work challenging and engaging in the best way. After years of research, bringing a project to life as a clinical trial is incredibly energising. Each trial represents progress, and each milestone is one step closer to getting potential new medicines to patients.” Hanna Sundström BSc MSc PhD (Biochemistry) | Zurich, Switzerland Global Regulatory Strategy, Director, CSL Vifor “At CSL, I help guide promising new therapies through sometimes quite complicated regulatory and clinical pathways so these medicines can reach the patients who need them. I translate the science into something that health authorities can assess and ultimately approve as a new medicine for patients. I hope that the scientific community can continue to close the gap between early scientific discovery and real patient impact so that we can move even faster to create more targeted treatments for conditions that have limited options, or others where there are still no therapies. It becomes so meaningful when we remember why we do this.” 24 | CSL IMPACT REPORT 2026
RkJQdWJsaXNoZXIy MjE2NDg3